Where Innovation Creates Real Impact

Innovation is more than a concept — it is the driving force behind meaningful healthcare advancements. At Genesis Medtech, we believe technology should do more than exist; it should create impact.

Innovation with Purpose

Innovation at Genesis MedTech begins with a purpose. We are guided by a deep understanding of surgical needs, a relentless pursuit of quality, and a global team dedicated to solving real clinical challenges.

Innovation in Action

Here’s how our purpose comes to life — through real solutions designed to support surgeons and improve patient outcomes.

Optimise Outcomes with AI

SurgeryView.AI. integrates into surgical workflows, delivering data-driven insights and performance analytics. It empowers surgeons with evidence-based feedback to refine techniques and improve outcomes.

Precision, Control, Confidence

OMNIBOT offers surgeons precise control through advanced robotic instruments and exceptional visualization. Its consistency enables safer, better outcomes for patients across specialties, even in complex surgeries.

Expanding Possibilities

Designed for patients with aortic regurgitation, the J-Valve System™'s unique design enables precise, stable placement without relying on calcification, offering a safer option for high-risk patients who are not candidates for open-heart surgery.

Innovating for Safer Surgery

The world's first powered stapler with 90° articulation, the iReach Omnia offers enhanced manoeuvrability and control in anatomically restricted spaces. Its unique design enables better access and positioning, reducing the need for multiple stapler firings.

Where Innovation Begins​

At the heart of our innovation strategy is a network of dedicated R&D hubs,led by our flagship Genesis Innovation Centre.

Learn more about Genesis Innovation Centre

Global Innovation Network

Our R&D teams work closely with healthcare practitioners to create solutions that are practical, scalable, and cost-efficient, making better healthcare more accessible to patients around the world.

Revenue reinvested into R&D

0%+

Total number of patents

0+

Global R&D and Innovation Centres

0